1,397 articles
A surprise immune cell steps in when the expected one is absent, keeping mRNA cancer vaccines effective and opening new design possibilities.
Johns Hopkins scientists reveal how fetal cone cells transform under vitamin A signals, opening doors to vision-restoring therapies.
A modified Mediterranean diet with low protein and tuned methionine levels boosted healthspan and slashed body fat in older mice.
A compound in lettuce called lactucin shows real sleep benefits. A double-blind trial found lettuce seed oil helped 70% of insomniacs improve within a week.
New NCI-backed analysis finds men face significantly higher odds of late-stage cancer diagnosis across 20 cancer types, worsening survival odds.
A large records analysis finds newer diabetes drugs carry differing autoimmune risk profiles, with DPP-4 inhibitors standing out most.
Wainua failed to beat placebo in reducing cardiovascular death in ATTR-CM patients, sending both companies' shares sharply lower.
The U.S. health moonshot agency launches THRIVE, funding seven teams to develop personalized gene editing treatments with clinical trials in 3 years.
A new proposal wants to grow cells deep underground to test whether cosmic muon radiation accelerates epigenetic aging clocks.
DiamiR Biosciences presents three studies on blood biomarkers and APOE genotyping for early Alzheimer's detection at London's AAIC.
Nanoscope and Catalent are scaling up production of a gene therapy that reprograms retinal cells to restore sight in degenerative eye diseases.
Alterity Therapeutics gains FDA alignment for a pivotal Phase 3 trial of ATH434, targeting iron buildup and protein pathology in multiple system atrophy.
